Federal award
ASPERA BIOMEDICINES, INC.
80JSC025PA001
Contract
Obligated and Ceiling
- Obligated (net)
- $6,450,000.00
- Ceiling (potential value, not spending)
- $12,984,612.60
- Current value
- $12,984,612.60
- Gross positive obligations
- $6,450,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ASPERA BIOMEDICINES, INC. · NYB9H3MV8C15
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ASPERA BIOMEDICINES, INC. · NYB9H3MV8C15
- Awarding agency
- NASA · sub-agency 8000 · office 80JSC0
- Funding agency
- NASA · sub-agency 8000
- Product or service (PSC)
- AN23
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- 80JSC025PA001
- Award type code
- B
- Actions
- 8 · Dec 5, 2024 to Sep 1, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 1, 2026 | FY2026 | P00007 | B | $3,210,000.00 | — |
| Jun 26, 2026 | FY2026 | P00006 | M | $0.00 | — |
| Apr 17, 2026 | FY2026 | P00005 | C | $0.00 | — |
| Jan 30, 2026 | FY2026 | P00004 | C | $1,080,000.00 | — |
| Nov 20, 2025 | FY2026 | P00003 | M | $0.00 | — |
| Sep 2, 2025 | FY2025 | P00002 | C | $720,000.00 | — |
| Dec 5, 2024 | FY2025 | 0 | — | $650,000.00 | — |
| Dec 5, 2024 | FY2025 | P00001 | C | $790,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.